Considering CareMax Inc. (CMAX) as a potential investment: What Should You Do?

The price of CareMax Inc. (NASDAQ: CMAX) closed at $3.56 in the last session, up 2.01% from day before closing price of $3.49. In other words, the price has increased by $+0.0700 from its previous closing price. On the day, 670148 shares were traded. CMAX stock price reached its highest trading level at $3.6300 during the session, while it also had its lowest trading level at $3.3800.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".



We take a closer look at CMAX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.80 and its Current Ratio is at 4.80. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.39.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 07, 2022, initiated with a Hold rating and assigned the stock a target price of $7.50.

On January 07, 2022, UBS started tracking the stock assigning a Buy rating and target price of $14.

On October 20, 2021, Jefferies started tracking the stock assigning a Buy rating and target price of $15.Jefferies initiated its Buy rating on October 20, 2021, with a $15 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 13 when Cho Bryan bought 10,000 shares for $3.46 per share. The transaction valued at 34,600 led to the insider holds 23,500 shares of the business.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.82 while its Price-to-Book (P/B) ratio in mrq is 0.66.

Stock Price History:

Over the past 52 weeks, CMAX has reached a high of $9.23, while it has fallen to a 52-week low of $2.77. The 50-Day Moving Average of the stock is 4.1376, while the 200-Day Moving Average is calculated to be 5.3179.

Shares Statistics:

According to the various share statistics, CMAX traded on average about 684.70K shares per day over the past 3-months and 1.4M shares per day over the past 10 days. A total of 87.41M shares are outstanding, with a floating share count of 77.58M. Insiders hold about 0.20% of the company’s shares, while institutions hold 57.10% stake in the company. Shares short for CMAX as of Jan 30, 2023 were 6.65M with a Short Ratio of 5.57M, compared to 4.65M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 5.98% and a Short% of Float of 7.81%.

Earnings Estimates

The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.07, while EPS last year was -$0.04. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.01 and low estimates of -$0.12.

Analysts are recommending an EPS of between -$0.59 and -$0.6 for the fiscal current year, implying an average EPS of -$0.59. EPS for the following year is -$0.29, with 4 analysts recommending between -$0.15 and -$0.55.

Revenue Estimates

According to 5 analysts, the current quarter’s revenue is expected to be $149.38M. It ranges from a high estimate of $160.68M to a low estimate of $145.14M. As of the current estimate, CareMax Inc.’s year-ago sales were $118.31M, an estimated increase of 26.30% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $209.05M, an increase of 52.70% over than the figure of $26.30% in the same quarter last year. There is a high estimate of $248M for the next quarter, whereas the lowest estimate is $178.65M.

A total of 5 analysts have provided revenue estimates for CMAX’s current fiscal year. The highest revenue estimate was $627.55M, while the lowest revenue estimate was $612.01M, resulting in an average revenue estimate of $616.23M. In the same quarter a year ago, actual revenue was $295.76M, up 108.40% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $818.53M in the next fiscal year. The high estimate is $1.03B and the low estimate is $650.11M. The average revenue growth estimate for next year is up 32.80% from the average revenue estimate for this year.